Preventice Solutions

What Preventice Solutions does

Preventice Solutions, founded in 2007 and headquartered in Houston, Texas, developed a portfolio of mobile cardiac health solutions built around the BodyGuardian family of FDA-cleared, wearable ECG monitors designed for continuous 24/7 use. The BodyGuardian MINI and BodyGuardian MINI PLUS collect cardiac rhythm data from patients and transmit it to healthcare providers for arrhythmia diagnosis, with proprietary AI algorithms BeatLogic and ECG Insight performing automated rhythm analysis and clinical interpretation to reduce physician review burden. BodyGuardian 360 powered by Prevounce extends the platform with EMR integration and workflow tools for practice management connectivity.

The company operated a B2B2C model selling devices and subscription monitoring services to physicians, clinics, and hospitals, who then prescribed monitors to patients. Revenue derived from three streams: hardware sales of the BodyGuardian devices, recurring subscription-based remote monitoring services, and reimbursement and billing support (including Personapay patient billing integration and Medicare-certified diagnostic facilities obtained through the acquisition of AMI Cardiac Monitoring). Pricing was quote-based through healthcare provider ordering systems with multi-year contracts and Medicare/insurance reimbursement pathways.

In 2021, Boston Scientific Corporation acquired Preventice Solutions for $925 million, integrating it as Boston Scientific Cardiac Diagnostics Inc., a wholly owned subsidiary. The acquisition embedded Preventice's BodyGuardian technology and AI tools within Boston Scientific's broader cardiac diagnostics portfolio (HeartLogic, AVVIGO+, LUX-Dx II+) and gave it access to Boston Scientific's global distribution network ($16.7B in 2024 net sales, up 17.6% YoY). The company now serves healthcare providers across North America and Europe.

Name

Preventice Solutions

Legal name

Boston Scientific Cardiac Diagnostics Inc.

Website

https://preventicesolutions.com

Company type

Private

Founded year

2007

Operating status

Acquired

Headcount range

501–1,000 employees

Short description

Preventice Solutions (now Boston Scientific Cardiac Diagnostics) provides FDA-cleared BodyGuardian wearable ECG monitors and AI-driven arrhythmia analysis (BeatLogic, ECG Insight) to physicians, clinics, and hospitals for continuous remote cardiac monitoring, operating as a wholly owned subsidiary of Boston Scientific Corporation.

Ownership category

akta.pro rank

Product category

Remote Cardiac Monitoring Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Measuring & Controlling Devices, Nec (3829)

akta.pro primary industry

Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)

akta.pro secondary industries

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Cardiology Telemedicine Platforms (HLALAGAB)

Keywords

• Remote cardiac monitoring
• Wearable ECG devices
• Arrhythmia detection
• AI diagnostic software
• Cardiac health solutions

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Wearable Cardiac Monitoring Devices: Sale of BodyGuardian remote cardiac monitors (BodyGuardian MINI, BodyGuardian MINI PLUS) to healthcare providers and patients. Devices are FDA-cleared and designed for extended wear (24/7 usage, waterproof).
2. Remote Patient Monitoring Services: Subscription-based monitoring services where healthcare professionals receive continuous ECG data transmission and AI-powered analysis to support cardiac arrhythmia diagnosis.
3. Reimbursement and Billing Services: Patient billing and reimbursement support services including Personapay integration for patient payments, Medicare-certified diagnostic facilities through acquired AMI Cardiac Monitoring.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Preventice Solutions develops and sells the BodyGuardian portfolio of FDA-cleared wearable cardiac monitors (BodyGuardian MINI and MINI PLUS) that patients wear 24/7 to collect continuous ECG data. The devices are paired with AI-powered diagnostic software (BeatLogic and ECG Insight) for arrhythmia detection and clinical interpretation, along with BodyGuardian 360 powered by Prevounce for EMR integration and clinical workflow management. The company operates a B2B2C model, selling primarily to healthcare providers who prescribe the monitors to their patients.

Product overview

Preventice Solutions, acquired by Boston Scientific in 2021 for $925 million, operates as Boston Scientific Cardiac Diagnostics and offers the BodyGuardian™ remote cardiac monitoring portfolio. The portfolio centers on wearable ECG devices (BodyGuardian MINI and MINI PLUS) that collect continuous cardiac data from patients wearing the monitors 24/7. These devices integrate with AI-powered diagnostic software including BeatLogic™ for automated arrhythmia detection and ECG Insight™ for clinical interpretation support. The offering also includes workflow integration solutions such as BodyGuardian 360 powered by Prevounce, enabling electronic medical record (EMR) connectivity and streamlined clinical workflows for healthcare providers. The product ecosystem combines comfortable, waterproof patient-worn hardware with cloud-based data analytics platforms to deliver actionable cardiac diagnostics.

Differentiator

Problem solved

Functional benefit

Brands

• BodyGuardian: Remote cardiac monitoring system - a comfortable, waterproof heart monitor that patients can wear 24/7, delivering ECG data to physicians for diagnosis.
• BodyGuardian MINI
• BodyGuardian MINI PLUS
• BeatLogic
• ECG Insight
• BodyGuardian 360 powered by Prevounce

Products and services

• BodyGuardian MINI A compact, wearable cardiac monitor designed for patients that provides continuous ECG monitoring in a small, unobtrusive, waterproof form factor suitable for 24/7 wear during normal daily activities. Prescribed by physicians for arrhythmia detection and cardiac diagnosis.
• BodyGuardian MINI PLUS An enhanced version of the BodyGuardian MINI with expanded monitoring capabilities for longer-term cardiac surveillance. A wearable, waterproof cardiac monitor providing continuous ECG data collection for physician diagnosis.
• BeatLogic An AI-powered cardiac rhythm analysis platform that identifies arrhythmias and delivers actionable accuracy in ECG interpretation for healthcare professionals. Part of Boston Scientific's BeatLogic suite for automated ECG analysis.
• ECG Insight An AI-driven ECG analysis tool that provides clinical insights and interpretation support for healthcare professionals reviewing cardiac monitoring data, synthesizing and retrieving clinical information to support physician decision-making.
• BodyGuardian 360 powered by Prevounce A comprehensive cardiac monitoring platform combining BodyGuardian hardware with Prevounce software for integrated patient management, workflow optimization, and EMR connectivity for healthcare providers.

Quantifiable outcome

• Wearable ECG monitors market projected to grow at 23.4% CAGR from $4.78B (2025) to $13.67B (2030)

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• InfoBionic: InfoBionic offers MoMe Kardia, a remote cardiac monitoring platform with AI arrhythmia detection; competes directly with BodyGuardian in the ambulatory ECG/MCT segment targeting cardiology practices.
• iRhythm Technologies: iRhythm is a direct competitor in ambulatory cardiac monitoring, offering the Zio patch-based ECG monitor with AI-assisted arrhythmia detection. Both companies compete for the same cardiologist/electrophysiologist customers and rely on CPT-code-based reimbursement.
• AliveCor: AliveCor makes KardiaMobile, a consumer/clinical ECG device with AI-driven arrhythmia detection, competing with BodyGuardian MINI in the short-duration, single-lead ECG category and increasingly in clinical remote monitoring.

Broad incumbents

• GE HealthCare: GE HealthCare offers MUSE cardiology information systems and broader cardiac diagnostics infrastructure; competes at the workflow and EMR-integration layer where BodyGuardian 360 also plays.
• Boston Scientific (parent): Boston Scientific is Preventice's parent company and a broader incumbent in cardiac care, offering insertable cardiac monitors (LUX-Dx), CRM devices, and HeartLogic heart failure diagnostics. Overlapping but larger portfolio that distributes BodyGuardian.
• Medtronic: Medtronic offers the LINQ insertable cardiac monitor and broader cardiac diagnostics portfolio, competing for the same cardiology customers with both implantable and external monitoring solutions.
• Philips (BioTel): Philips acquired BioTel (formerly LifeWatch) and provides remote cardiac monitoring services and MCT/event monitors, making it a broad incumbent competitor in the ambulatory cardiac monitoring services market.

Emerging players

• Apple (Apple Watch ECG): Apple Watch includes FDA-cleared ECG and atrial fibrillation detection features; while consumer-grade, it increasingly encroaches on the low-acuity end of the ambulatory cardiac monitoring market where BodyGuardian MINI operates.
• Biotricity: Biotricity offers Bioflux, a remote cardiac monitoring device with cloud platform; an emerging player competing in mobile cardiac telemetry with a comparable B2B2C physician-prescribed model.
• Qardio: Qardio offers remote cardiac monitoring devices and connected health platforms; smaller-scale competitor in the RPM space with overlap in cardiology practice adoption models.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/Preventice
• Facebookfacebook.com/preventicesolutions

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds2 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Preventice Solutions